The Latest Cardiac and Vascular News
VANCOUVER, June 4, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on June 4, 2019 in Vancouver, B.C. (the “Meeting”). At the Meeting, the shareholders of the Company (the “Shareholders”) re-elected […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that NHS England has extended HeartFlow’s participation in the Innovation and Technology Payment (ITP) program for an additional year. As part of the extension, NHS England will provide reimbursement to NHS hospitals for the usage of the HeartFlow FFRct Analysis, a non-invasive cardiac test for stable […]
IRVINE, Calif., June 3, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received notice of an unsolicited “mini-tender offer” by TRC Capital Corporation to purchase up to 1,000,000 shares, or approximately 0.48 percent of the […]
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it closed the previously announced sale of its NAMIC® fluid management portfolio to Medline Industries, Inc. on May 31, 2019 for $167.5 million. AngioDynamics has […]
Email Print Friendly Share June 03, 2019 07:52 ET | Source: BioSig Technologies, Inc. Santa Monica, CA, June 03, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that it received a […]
EDEN PRAIRIE, Minn., May 29, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, on May 23, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into employment with the Company. The equity awards […]
WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $25 million financing with Vensana Capital as the lead investor. Vensana was joined by existing investors including New Enterprise Associates (“NEA”), H.I.G. BioHealth Partners, and Quaker Partners. The Company reported closure […]
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced a $37 million financing with Vensana Capital and Gilde Healthcare as lead investors. They were joined by existing investors New Enterprise Associates (“NEA”) and Quaker Partners. The first tranche of the financing […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that it has named Dana G. Mead, Jr. as President and Chief Executive Officer (CEO). Mead also has been appointed to HeartFlow’s Board of Directors. Former President and CEO John H. Stevens, M.D., will continue to serve on the Board of Directors and […]
Xellera Therapeutics Limited will accelerate the progression of Novoheart’s current business scope Significantly enhances Novoheart’s liquidity, gaining access to approximately C$22,500,000 cash VANCOUVER, British Columbia, May 28, 2019 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) announced that effective on May 27, 2019, it has entered into […]
